Skip to main content
Log in

Exhaled breath markers in patients with obstructive sleep apnoea

  • Original Article
  • Published:
Sleep and Breathing Aims and scope Submit manuscript

Abstract

The objectives of the present study were to assess the level of exhaled breath markers indicating airway inflammation and oxidative stress in patients with obstructive sleep apnoea syndrome (OSAS) in comparison with non-apnoeic (obese and non-obese) subjects and investigate whether therapy with continuous positive airway pressure (CPAP) can modify them. The design was a retrospective observational study, set in Evgeneidio Hospital. Twenty-six OSAS patients and nine obese and 10 non-obese non-apnoeic subjects participated in this study. We measured nasal nitric oxide (nNO), exhaled nitric oxide (eNO), exhaled carbon monoxide (eCO) in exhaled breath, and 8-isoprostane, leukotriene B4 (LTB4), nitrates, hydrogen peroxide (H2O2), and pH in exhaled breath condensate (EBC) before and after 1 month of CPAP therapy. The levels of eNO and eCO were higher in OSAS patients than in control subjects (p < 0.05). Nasal NO was higher in OSAS patients than in obese controls (p < 0.01). The level of H2O2, 8-isoprostane, LTB4, and nitrates were elevated in OSAS patients in comparison with obese subjects (p < 0.01). Conversely, pH was lower in OSAS patients than in non-apnoeic controls (p < 0.01). One month of CPAP therapy increased pH (p < 0.05) and reduced eNO (p < 0.001) and nNO (p < 0.05). Apnea/hypopnoea index was positively correlated with 8-isoprostane (r = 0.42; p < 0.05), LTB4 (r = 0.35; p < 0.05), nitrates (r = 0.54; p < 0.001), and H2O2 (r = 0.42; p < 0.05). Airway inflammation and oxidative stress are present in the airway of OSAS patients in contrast to non-apnoeic subjects. Exhaled breath markers are positively correlated with the severity of OSAS. One-month administration of CPAP improved airway inflammation and oxidative stress.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328:1230–1235

    Article  PubMed  CAS  Google Scholar 

  2. Peker Y, Hedner J, Norum J, Kraiczi H, Carlson J (2002) Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea. A 7-year follow-up. Am J Respir Crit Care Med 166:159–165

    Article  PubMed  Google Scholar 

  3. Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep disordered breathing and hypertension. N Engl J Med 342:1378–1384

    Article  PubMed  CAS  Google Scholar 

  4. Mathur S, Devaraj S, Jialal I (2002) Accelerated atherosclerosis, dyslipidemia, and oxidative stress in end-stage renal disease. Curr Opin Nephrol Hypertens 11:141–147

    Article  PubMed  Google Scholar 

  5. Lavie L (2003) Obstructive sleep apnoea—an oxidative stress disorder. Sleep Med Rev 7:35–51

    Article  PubMed  Google Scholar 

  6. Svatikova A, Wolk R, Lerman L, Juncos L, Greene E, Mc Connell J, Somers V (2005) Oxidative stress in obstructive sleep apnoea. Eur Heart J 26:2435–2439

    Article  PubMed  CAS  Google Scholar 

  7. Carpagnano G, Kharitonov S, Resta O, Foschino-Barbaro M, Gramiccioni E, Barnes P (2002) Increased 8-isoprostane and Interleukin-6 in breath condensate of obstructive sleep apnoea patients. Chest 122:1162–1167

    Article  PubMed  CAS  Google Scholar 

  8. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, Grimminger F (2000) Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:566–570

    PubMed  CAS  Google Scholar 

  9. Wali S, Bahammam A, Massaeli H, Pierce G, Iliskovic N, Singal P, Kryger M (1998) Susceptibility of LDL to oxidative stress in obstructive sleep apnea. Sleep 21:290–296

    PubMed  CAS  Google Scholar 

  10. Muns G, Rubistein I, Bergmann K (1995) Phagocytosis and oxidative burst of blood phagocytes in chronic obstructive airway disease. Scand J Infect Dis 27:369–373

    Article  PubMed  CAS  Google Scholar 

  11. Dyugovskaya L, Lavie P, Lavie L (2002) Increased adhesion molecules expression and production of reactive oxygen species in leykocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934–939

    PubMed  Google Scholar 

  12. Olopade C, Christon J, Zakkar M, Hua C, Swedler W, Scheff P, Rubinstein I (1997) Exhaled pentane and nitric oxide levels in patients with obstructive sleep apnea. Chest 111:1500–1504

    Article  PubMed  CAS  Google Scholar 

  13. Agusti AG, Barbe F, Togores B (1999) Exhaled nitric oxide in patients with sleep apnea. Sleep 22:231–235

    PubMed  CAS  Google Scholar 

  14. Kharitonov S, Barnes P (2001) Exhaled markers of inflammation. Curr Opin Allergy Clin Immunol 1:217–224

    PubMed  CAS  Google Scholar 

  15. Rechtschaffen A, Kales A (eds) (1968) A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. National Institutes of Health, Bethesda

  16. American Academy of Sleep Medicine Task Force (1999) Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep 22:667–689

    Google Scholar 

  17. ATS/ERS Task Force on Exhaled Breath Condensate (2005) Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 26:523–548

    Article  Google Scholar 

  18. Hunt JF, Fang K, Malik R, Snyder A, Malhotra N, Platts-Mills TAE, Gaston B (2000) Endogenous airway acidification: implications for asthma pathology. Am J Respir Crit Care Med 161:694–699

    PubMed  CAS  Google Scholar 

  19. Gallati H, Pracht I (1985) Horseradish peroxidase: kinetic studies and optimization of peroxidase activity determination using the substrates H2O2 and 3,3,5,5-tetramethylbenzidine. J Clin Chem Clin Biochem 23:453–460

    PubMed  CAS  Google Scholar 

  20. Kharitonov S, Barnes P (2001) Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 163:1693–1722

    PubMed  CAS  Google Scholar 

  21. Janssen-Heininger Y, Persinger R, Korn S, Pantano C, McElhinney B, Reynaert N, Langen R, Ckless K, Shrivastava P, Poynter M (2002) Reactive nitrogen species and cell signaling: implications for death or survival of lung epithelium. Am J Respir Crit Care Med 166:S9–S16

    Article  PubMed  Google Scholar 

  22. Struben V, Wieringa M, Feenstra L, De Jongste J (2006) Nasal nitric oxide and nasal allergy. Allergy 61:665–670

    Article  PubMed  CAS  Google Scholar 

  23. Kharitonov S, Barnes P (2006) Exhaled biomarkers. Chest 130:1541–1546

    Article  PubMed  Google Scholar 

  24. Predi P, Kharitonov S, Barnes P (2002) Analysis of expired air for oxidation products. Am J Respir Crit Care Med 166:S31–S37

    Article  Google Scholar 

  25. Montuschi P, Ciabattoni G, Paredi P, Pantelidis P, du Bois RM, Kharitonov S, Barnes P (1998) 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases. Am J Respir Crit Care Med 158:1524–1527

    PubMed  CAS  Google Scholar 

  26. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro M, Gramiccioni E, Barnes P (2003) 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124:1386–1392

    Article  PubMed  CAS  Google Scholar 

  27. Vgontzas A, Papanicolaou D, Bixler E Kales A, Tyson K, Chrousos G (1997) Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. Clin Endocrinol Metab 82:1313–1316

    Article  CAS  Google Scholar 

  28. Nicosia S, Capra V, Rovati G (2001) Leukotriens as mediators of asthma. Pulm Pharmacol Ther 14:3–19

    Article  PubMed  CAS  Google Scholar 

  29. Montuschi P, Barnes P (2002) Analysis of exhaled breath condensate for monitoring airway inflammation. Trends Pharmacol Sci 23:232–237

    Article  PubMed  CAS  Google Scholar 

  30. Kostikas K, Papatheodorou G, Ganas K, Psathakis K, Panagou P, Loukides S (2002) pH in expired breath condensate of patients with inflammatory airway diseases. Am J Respir Crit Care Med 165:1364–1370

    Article  PubMed  Google Scholar 

  31. Leung T, Li C, Lam C, Au C, Yung E, Chan I, Wong G, Fok T (2004) The relationship between obesity and asthmatic airway inflammation. Pediatr Allergy Immunol 15:344–350

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ioannis Koutsourelakis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Petrosyan, M., Perraki, E., Simoes, D. et al. Exhaled breath markers in patients with obstructive sleep apnoea. Sleep Breath 12, 207–215 (2008). https://doi.org/10.1007/s11325-007-0160-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11325-007-0160-8

Keywords

Navigation